Zofran Birth Defects Lawsuit Filed After Child Born With Cleft Palate

   

Zofran Birth Defects Lawsuit Attorneys Allege Use Of Zofran During Pregnancy Causes Cleft Lip, Cleft Palate, Heart Murmur And Other Birth Defects.

Zofran-birth-defects-lawsuit-lawyer-attorney-9Another Zofran birth defects lawsuit has joined the pending litigation against GlaxoSmithKline over its anti-nausea drug. This Zofran complaint was filed on behalf of Georgia family whose child was born in 2004 with a cleft palate allegedly due to the mother being prescribed Zofran during her first trimester of pregnancy. Similar Zofran birth defects lawsuits contend that Zofran causes newborns to suffer numerous birth defects such as cleft palate, heart murmur, atrial septal defect (hole in the heart), musculoskeletal defects and other abnormalities.(In Re: Zofran (Ondansetron) Products Liability Litigation – MDL No. 2657)

“Zofran birth defect lawsuits stress that not only are children born with abnormalities, they will have to undergo numerous medical procedures in the future to repair the deformities,” says Dr. François Blaudeau, co-founder of Southern Med Law, which is currently evaluating potential Zofran lawsuits on behalf of families who believe their child was born with a birth defect due to the anti-nausea medication. If you or a loved one have found themselves in faced with Zofran side-effects contact one of the firms attorneys for a free case evaluation by calling 1-205-547-5525 or visit www.southernmedlaw.com for more information and to fill out a contact form.

Zofran Birth Defects Lawsuit Alleges Cleft Palate Repair For New Born

The Zofran birth defects lawsuit states that the child has already undergone various surgeries, including cleft palate repair, a myringotomy which is an incision into the eardrum to relieve pressure or drain fluid, and a sleep study. According to the complaint, the child is expected to undergo more surgeries due to having a “dysmorphic appearance of the mandible” that will require further medical attention as the child grows. The mother maintains that had she known the “truth” about Zofran, which GlaxoSmithKline improperly marketed as a treatment for morning sickness in pregnant women, she would not have taken the drug and her child would have never been injured as the Zofran birth defects complaint described. (Case No.1:16-cv-10780)

What Is The Anti-Nausea Medication Zofran

Zofran (ondansetron) is an anti-emetic drug approved by the U.S. Food and Drug Administration (FDA) to treat the side effects of nausea and vomiting associated with chemotherapy, radiation, and surgeries. The pharmaceutical giant marketed Zofran to expectant mothers as a treatment for morning sickness. However, GlaxoSmithKline was cited by the federal government for illegally promoting Zofran and its other drugs for uses that were not approved by the FDA. In June 2012, the U.S. Justice Department announced that GlaxoSmithKline agreed to pay $3 billion to resolve civil and criminal claims filed against the company.
[justice.gov/opa/pr/glaxosmithkline-plead-guilty-and-pay-3-billion-resolve-fraud-allegations-and-failure-report]

Internal Zofran Study Indicated Anti-Nausea Drug Had Potential For Serious Side-Effects

The pending Zofran birth defect claims state that Zofran became “the number one most prescribed drug for treating morning sickness in the United States” in the early 2000s, even though GlaxoSmithKline knew since the 1980s that the drug was unsafe for pregnant women. The company performed animal studies in the mid-1980s that showed Zofran crosses the placental barrier in mammals to expose the fetus to the drug. [ncbi.nlm.nih.gov/pmc/articles/PMC3299087/]

Due to the mounting Zofran birth defects lawsuit claims against GlaxoSmithKline, all federal Zofran claims were consolidated in the Massachusetts federal court in Boston for coordinated pretrial proceedings. The complaints commonly allege that GlaxoSmithKline improperly promoted Zofran as an anti-nausea drug to treat morning sickness in pregnant women resulting in babies suffering from birth defects such as cleft lip, cleft palate and heart defects. (In Re: Zofran (Ondansetron) Products Liability Litigation – MDL No. 2657)

About Southern Med Law and Filing A Zofran Birth Defects Lawsuit:

Southern Med Law is an experienced law firm providing legal representation to individuals from across the country who have been victims of dangerous drugs, medical malpractice, defective medical devices and other negligence lawsuits. The firms founder, Dr. François Blaudeau is an attorney and a practicing obstetrician/ gynecologist, the legal staff at Southern Med Law possesses a deep understanding of the complex medical and legal questions at issue in all manner of product liability and personal injury claims. They’re not afraid to take on the nation’s largest corporations in their pursuit of justice, and are committed to ensuring that all victims have access to the type of aggressive legal advocacy that assures success.

Contact:
Southern Med Law
François M. Blaudeau, MD JD FACHE FCLM Esquire
2224 1st Avenue North
Birmingham, Alabama 35203
Phone: 205-547-5525
Fax: 205-547-5526
francois@southernmedlaw.com
http://www.southernmedlaw.com
Medical Negligence/MedicalDevice/Pharma/Qui Tam

This entry was posted in Southern Med Law | Article. Bookmark the permalink.